OCT Agreement and Precision Study

Completed

Conditions studied: Normal Eyes, Eyes With Glaucoma, Eyes With Retinal Disease

In brief

To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.

Key facts

Study ID

NCT02045823

Run by

Topcon Medical Systems, Inc.

People needed

66

Starts

2014-01-01

Expected to finish

2014-03-01

Last updated by the study team

2022-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• New York VA — Jamaica, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.